REGULATORY

• Comprehensive Review of COVID Budgets Necessary: MOF Panel Chair
  April 17, 2023

• Japan to Set Out Measures Against Hay Fever, Promote Curative Therapy
  April 17, 2023

• Number of Mpox Cases Totals 109 in Japan: MHLW
  April 17, 2023

• Japan to Map Out Substantive Policy to Solve Pharma Industry Issues: Minister
  April 14, 2023

• Lower House Clears Bill to Amend Next-Gen Medical Infrastructure Law
  April 14, 2023

• LDP Pharma Study Group to Draw Up Resolution in May before Honebuto Paper
  April 13, 2023

• Lawmakers Split 50/50 on Abortion Pill, No Conclusion at LDP Panel
  April 13, 2023

• Ultomiris’ NMOSD Nod Up for Advisory Panel Review on April 26
  April 13, 2023

• Mpox Cases Top 100 in Japan, 10 New Patients Confirmed
  April 13, 2023

• Pandemic Response Agency to Be Set Up as Early as September: Minister Goto
  April 12, 2023

• Japan Aims to Cut Use of IV Carbapenem Antibiotics by 20%: AMR Action Plan
  April 11, 2023

• LDP Project Team Calls for Price Maintenance During Patent Period and Rethink of Off-Year Cuts
  April 11, 2023

• Skyrizi’s Palmoplantar Pustulosis Use on PAFSC Agenda on April 24
  April 11, 2023

• China Envoy Says Spying Allegations of Astellas Employee Becoming Certain
  April 10, 2023

• 9-Valent HPV Vaccine Program Poses Opportunity to Boost Inoculation Rate: LDP Lawmaker
  April 7, 2023

• Japan Needs Guidelines on Conditional Approval for Regenerative Medicines: Lawmakers
  April 7, 2023

• Tokyo Likely to See Next COVID Spike around First Half of May: Experts
  April 7, 2023

• MHLW to Make Case-by-Case Decisions on Use of “Specified Clinical Research” Data in Regulatory Filings
  April 6, 2023

• Expert Panel Questions Requirement for Generic Listing in All Versions
  April 5, 2023

• Expert Panel Mixed on Macroeconomic Indexing of Drug Cost; Govt Urged to Quit Targeting Pharma for Savings
  April 5, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• 92
• 93
• …
• Next ›
• 最終 »